RecruitingNot ApplicableNCT07284030

Psychoeducation and Well-Being After Breast Cancer

The Effect of a Web-Based Supportive Psychoeducation Program on Psychological Well-Being, Quality of Life and Fear of Recurrence Applied to Patients Who Completed Active Breast Cancer Treatment

Sponsor

Yasemin Nazli

Enrollment

72 participants

Start Date

May 1, 2025

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Breast Cancer Survivors Breast - Female Psycho-Oncology

Summary

This randomized controlled trial evaluates the effectiveness of a web-based psychoeducation program on psychological well-being and quality of life in breast cancer survivors who completed active treatment at least one year earlier. Seventy-two women will be randomly assigned to either a 6-week online psychoeducation program plus standard care or standard care alone. The intervention consists of weekly 30-45 minute online sessions focusing on coping strategies, psychosocial adjustment, quality of life, and psychological well-being. Primary outcomes include psychological well-being, fear of cancer recurrence, quality of life, and hopelessness, assessed at baseline, post-intervention, and 2-month follow-up.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing an online psychoeducation program to improve emotional well-being and quality of life in women who have completed breast cancer treatment and are now in remission. **You may be eligible if...** - You are a female breast cancer survivor between 18 and 65 years old - You finished active treatment (surgery, chemotherapy, and/or radiation) at least 12 months ago - You are currently in remission with no signs of active cancer - You can read and write in Turkish - You have a computer or smartphone with internet access and can join Zoom video sessions **You may NOT be eligible if...** - Your cancer has returned or spread (metastatic disease) - You have an active psychiatric disorder that requires treatment - You have cognitive difficulties that would prevent you from participating online - You are currently receiving active cancer treatment (hormone therapy is allowed) - You are enrolled in another psychosocial intervention study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALWeb-Based Psychoeducation Program

Six-week structured psychoeducation program delivered online through www.onkodestek.org website and weekly Zoom sessions. Topics include living with breast cancer, managing psychosocial issues, improving quality of life, psychological well-being, and finding hope and meaning. Each session lasts 30-45 minutes.

Locations(1)

Breast Cancer Outpatient Clinic

Istanbul, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07284030

Related Trials

Genomic Services Research Program

NCT025959571 location

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

NCT052833304 locations

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

NCT070671381 location

Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)

NCT068852031 location

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

NCT06103864316 locations